Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Csuka

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Postgraduate Medicine|September 1, 1982
Interpretation of laboratory results in the elderly. 1. A clinician's guide to hematologic and hepatorenal function testsS R Gambert, M E Csuka, E H Duthie, et al.
The Journal of Rheumatology|August 1, 1985
Gold induced aplastic anemia. Complete response to corticosteroids, plasmapheresis, and N-acetylcysteine infusionR M Hansen, M E Csuka, D J McCarty, et al.
Clinical Pharmacology and Therapeutics|December 1, 1992
Activity of oxidative routes of metabolism of debrisoquin, mephenytoin, and dapsone is unrelated to the pathogenesis of vinyl chloride-induced diseaseC Black, G May, M E Csuka, et al.
The Journal of Rheumatology|January 1, 1997
Concurrent gout and Mycobacterium tuberculosis arthritisJ P Lorenzo, M E Csuka, B A Derfus, et al.
The Journal of Rheumatology|May 1, 1991
Bone remodelling after growth factor and cyclosporine A therapy for aplastic anemiaB A Derfus, M E Csuka, G F Carrera, et al.
Multiple Sclerosis and Related Disorders|December 5, 2019
Determinants of low bone mineral density in people with multiple sclerosis: Role of physical activityBrice T Cleland, Paula Papanek, Benjamin A Ingraham, et al.
Clinical Pharmacology and Therapeutics|September 1, 1990
Scleroderma is associated with differences in individual routes of drug metabolism: a study with dapsone, debrisoquin, and mephenytoinD G May, C M Black, N J Olsen, et al.
Clinical and Experimental Rheumatology|November 6, 2014
Pulmonary hypertension and interstitial lung disease within PHAROS: impact of extent of fibrosis and pulmonary physiology on cardiac haemodynamic parametersA Fischer, J J Swigris, M B Bolster, et al.
Arthritis Care & Research|September 17, 2021
Clinical and Molecular Findings After Autologous Stem Cell Transplantation or Cyclophosphamide for Scleroderma: Handling Missing Longitudinal DataLynette Keyes-Elstein, Ashley Pinckney, Ellen Goldmuntz, et al.
Arthritis and Rheumatism|February 28, 2009
MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trialLorinda Chung, Lee Shapiro, David Fiorentino, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Postgraduate Medicine|September 1, 1982
Interpretation of laboratory results in the elderly. 1. A clinician's guide to hematologic and hepatorenal function testsS R Gambert, M E Csuka, E H Duthie, et al.
The Journal of Rheumatology|August 1, 1985
Gold induced aplastic anemia. Complete response to corticosteroids, plasmapheresis, and N-acetylcysteine infusionR M Hansen, M E Csuka, D J McCarty, et al.
Clinical Pharmacology and Therapeutics|December 1, 1992
Activity of oxidative routes of metabolism of debrisoquin, mephenytoin, and dapsone is unrelated to the pathogenesis of vinyl chloride-induced diseaseC Black, G May, M E Csuka, et al.
The Journal of Rheumatology|January 1, 1997
Concurrent gout and Mycobacterium tuberculosis arthritisJ P Lorenzo, M E Csuka, B A Derfus, et al.
The Journal of Rheumatology|May 1, 1991
Bone remodelling after growth factor and cyclosporine A therapy for aplastic anemiaB A Derfus, M E Csuka, G F Carrera, et al.
Multiple Sclerosis and Related Disorders|December 5, 2019
Determinants of low bone mineral density in people with multiple sclerosis: Role of physical activityBrice T Cleland, Paula Papanek, Benjamin A Ingraham, et al.
Clinical Pharmacology and Therapeutics|September 1, 1990
Scleroderma is associated with differences in individual routes of drug metabolism: a study with dapsone, debrisoquin, and mephenytoinD G May, C M Black, N J Olsen, et al.
Clinical and Experimental Rheumatology|November 6, 2014
Pulmonary hypertension and interstitial lung disease within PHAROS: impact of extent of fibrosis and pulmonary physiology on cardiac haemodynamic parametersA Fischer, J J Swigris, M B Bolster, et al.
Arthritis Care & Research|September 17, 2021
Clinical and Molecular Findings After Autologous Stem Cell Transplantation or Cyclophosphamide for Scleroderma: Handling Missing Longitudinal DataLynette Keyes-Elstein, Ashley Pinckney, Ellen Goldmuntz, et al.
Arthritis and Rheumatism|February 28, 2009
MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trialLorinda Chung, Lee Shapiro, David Fiorentino, et al.
Pageof 3